New Jersey A 5020: Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.

Status: Introduced, Referred to Assembly Financial Institutions and Insurance Committee (as of 2026-05-07)

State: New Jersey · Session: 222 · Bill: A 5020

Sponsors: Peterpaul, Luanne M., Esq.

View New Jersey A 5020 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.